Madrigal Pharmaceuticals
MDGL
MDGL
256 hedge funds and large institutions have $6.41B invested in Madrigal Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 111 increasing their positions, 64 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
4% less funds holding
Funds holding: 267 → 256 (-11)
11% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 54
Holders
256
Holding in Top 10
14
Calls
$312M
Puts
$186M
Top Buyers
| 1 | +$426M | |
| 2 | +$60.8M | |
| 3 | +$42.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$35.4M |
Top Sellers
| 1 | -$54.6M | |
| 2 | -$52.6M | |
| 3 | -$46.3M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$32.4M |
| 5 |
AG
Artal Group
Luxembourg
|
-$29.5M |